Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 1052 of 3330
Next
>>
>
26276 to 26300 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
BT-474	HER2amp	Luminal	FR180204	ERK1/2	MAPK	0.16	uM	12291.166	0.9226	0.7471	0.5962
BT-474	HER2amp	Luminal	FR180204	ERK1/2	MAPK	0.8	uM	12291.166	0.8856	0.6311	0.5962
BT-474	HER2amp	Luminal	FR180204	ERK1/2	MAPK	4	uM	12291.166	0.9075	0.6994	0.5962
BT-474	HER2amp	Luminal	FR180204	ERK1/2	MAPK	20	uM	12291.166	0.8116	0.4091	0.5962
BT-474	HER2amp	Luminal	FR180204	ERK1/2	MAPK	100	uM	12291.166	0.5277	-0.3155	0.5962
BT-483	HR+	Luminal	FR180204	ERK1/2	MAPK	0.0000853	uM	10696.149	0.9506	0.8357	0.5906
BT-483	HR+	Luminal	FR180204	ERK1/2	MAPK	0.000427	uM	10696.149	0.9193	0.7343	0.5906
BT-483	HR+	Luminal	FR180204	ERK1/2	MAPK	0.00213	uM	10696.149	0.9960	0.9866	0.5906
BT-483	HR+	Luminal	FR180204	ERK1/2	MAPK	0.0107	uM	10696.149	0.9910	0.9696	0.5906
BT-483	HR+	Luminal	FR180204	ERK1/2	MAPK	0.0533	uM	10696.149	0.9792	0.9301	0.5906
BT-483	HR+	Luminal	FR180204	ERK1/2	MAPK	0.267	uM	10696.149	0.9742	0.9133	0.5906
BT-483	HR+	Luminal	FR180204	ERK1/2	MAPK	1.33	uM	10696.149	0.9982	0.9938	0.5906
BT-483	HR+	Luminal	FR180204	ERK1/2	MAPK	6.67	uM	10696.149	0.9830	0.9426	0.5906
BT-483	HR+	Luminal	FR180204	ERK1/2	MAPK	33.3	uM	10696.149	0.9021	0.6798	0.5906
BT-483	HR+	Luminal	FR180204	ERK1/2	MAPK	0.000256	uM	11855.161	0.9068	0.6970	0.5957
BT-483	HR+	Luminal	FR180204	ERK1/2	MAPK	0.00128	uM	11855.161	0.9178	0.7318	0.5957
BT-483	HR+	Luminal	FR180204	ERK1/2	MAPK	0.0064	uM	11855.161	0.9694	0.8984	0.5957
BT-483	HR+	Luminal	FR180204	ERK1/2	MAPK	0.032	uM	11855.161	0.9119	0.7132	0.5957
BT-483	HR+	Luminal	FR180204	ERK1/2	MAPK	0.16	uM	11855.161	0.9203	0.7396	0.5957
BT-483	HR+	Luminal	FR180204	ERK1/2	MAPK	0.8	uM	11855.161	0.8736	0.5940	0.5957
BT-483	HR+	Luminal	FR180204	ERK1/2	MAPK	4	uM	11855.161	0.9429	0.8120	0.5957
BT-483	HR+	Luminal	FR180204	ERK1/2	MAPK	20	uM	11855.161	0.8620	0.5588	0.5957
BT-483	HR+	Luminal	FR180204	ERK1/2	MAPK	100	uM	11855.161	0.7313	0.1826	0.5957
BT-549	TNBC	Basal B	FR180204	ERK1/2	MAPK	0.000256	uM	12305.166	0.8876	0.9210	2.9556
BT-549	TNBC	Basal B	FR180204	ERK1/2	MAPK	0.00128	uM	12305.166	0.9419	0.9599	2.9556

|<
<<
Previous
Page 1052 of 3330
Next
>>
>
26276 to 26300 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)